Avalo Therapeutics (AVTX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Avalo Therapeutics (AVTX) over the last 11 years, with Q3 2025 value amounting to $1.1 million.
- Avalo Therapeutics' Interest & Investment Income rose 1587.14% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 10984.43%. This contributed to the annual value of $3.3 million for FY2024, which is 19707.35% up from last year.
- Per Avalo Therapeutics' latest filing, its Interest & Investment Income stood at $1.1 million for Q3 2025, which was up 1587.14% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Avalo Therapeutics' Interest & Investment Income registered a high of $1.2 million during Q4 2024, and its lowest value of -$1.6 million during Q3 2023.
- Moreover, its 5-year median value for Interest & Investment Income was -$239000.0 (2021), whereas its average is -$173263.2.
- In the last 5 years, Avalo Therapeutics' Interest & Investment Income tumbled by 697647.06% in 2022 and then surged by 140123.46% in 2024.
- Avalo Therapeutics' Interest & Investment Income (Quarter) stood at -$1.2 million in 2021, then rose by 19.85% to -$949000.0 in 2022, then skyrocketed by 108.54% to $81000.0 in 2023, then surged by 1401.23% to $1.2 million in 2024, then fell by 8.14% to $1.1 million in 2025.
- Its Interest & Investment Income stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.